Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
5(31%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
19%
Ph early_phase_1
7
44%
Ph phase_2
3
19%
Ph not_applicable
2
13%

Phase Distribution

10

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution15 total trials
Early Phase 1First-in-human
7(46.7%)
Phase 1Safety & dosage
3(20.0%)
Phase 2Efficacy & side effects
3(20.0%)
N/ANon-phased studies
2(13.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

16

all time

Status Distribution
Active(6)
Completed(9)
Other(1)

Detailed Status

Completed9
Recruiting5
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
5
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 17 (46.7%)
Phase 13 (20.0%)
Phase 23 (20.0%)
N/A2 (13.3%)

Trials by Status

not_yet_recruiting16%
completed956%
recruiting531%
unknown16%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT07061886Early Phase 1

Drug Effects on Mood and Behavior - Expectancy

Recruiting
NCT07490405

Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism

Not Yet Recruiting
NCT05474989Phase 2

LSD Treatment for Persons With Alcohol Use Disorder

Recruiting
NCT07309471Not Applicable

Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD

Recruiting
NCT07017478Early Phase 1

Mood Effects of Serotonin Agonists: Depression

Recruiting
NCT03866252Phase 2

LSD Therapy for Persons Suffering From Major Depression

Completed
NCT06899334Phase 1

Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants

Recruiting
NCT04227756Phase 1

Comparative Acute Effects of LSD, Psilocybin and Mescaline

Completed
NCT05670184Phase 1

The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality

Unknown
NCT03153579Phase 2

LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders

Completed
NCT03604744Early Phase 1

Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin

Completed
NCT03321136Early Phase 1

Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)

Completed
NCT03019822Early Phase 1

Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing

Completed
NCT02451072Not Applicable

The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers

Completed
NCT01878942Early Phase 1

Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study

Completed
NCT02308969Early Phase 1

Neuronal Correlates of Altered States of Consciousness

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16